Browsing Study Simulations

Displaying study simulation 376 - 400 of 579 in total
GWAS-ROCS ID Condition/Phenotype | GWAS Central ID PubMed IDSNPs (p-value)Heritability AUROC ROC Plot
GR00204Endometrial cancer | HGVRS501227135401
  • rs11263763 (3.0e-19)
  • rs2414098 (5.0e-13)
  • rs11841589 (5.0e-11)
  • rs13328298 (4.0e-10)
  • rs4733613 (3.0e-09)
  • rs937213 (2.0e-08)
  • rs2498796 (4.0e-08)
  • rs17232730 (4.0e-07)
  • (show allshow less)
0.0040.531305Gr00204
GR00203Endometrial cancer | HGVRS501127135401
  • rs11263763 (7.0e-17)
  • rs2414098 (2.0e-13)
  • rs13328298 (1.0e-11)
  • rs11841589 (6.0e-10)
  • rs4733613 (8.0e-09)
  • rs2498796 (4.0e-08)
  • rs937213 (2.0e-07)
  • (show allshow less)
0.0060.538208Gr00203
GR00202Endometrial cancer | HGVRS167421499250
  • rs4430796 (7.0e-10)
0.0020.520571Gr00202
GR00201End-stage renal disease in Type 1 diabetics (Women) | HGVRS370224029427
  • rs4972593 (4.0e-08)
0.0400.600398Gr00201
GR00200Early-onset obesity | HGVRS73119151714
  • rs1421085 (1.0e-28)
  • rs17782313 (5.0e-15)
  • rs1424233 (4.0e-13)
  • rs10508503 (2.0e-07)
  • rs1805081 (3.0e-07)
0.0250.579297Gr00200
GR00199Early onset inflammatory bowel disease | HGVRS72619915574
  • rs10500264 (4.0e-10)
  • rs2412973 (2.0e-09)
  • rs8049439 (2.0e-09)
  • rs1250550 (6.0e-09)
0.0050.535948Gr00199
GR00198Dupuytren's disease | HGVRS493228886342
  • rs16879765 (3.0e-81)
  • rs2598107 (2.0e-44)
  • rs629535 (4.0e-40)
  • rs611744 (1.0e-32)
  • rs7291412 (2.0e-30)
  • rs2912522 (4.0e-29)
  • rs12342106 (4.0e-26)
  • rs38904 (4.0e-23)
  • rs1042704 (2.0e-19)
  • rs6102095 (2.0e-18)
  • rs394563 (1.0e-17)
  • rs11672517 (2.0e-17)
  • rs1032466 (2.0e-17)
  • rs6496519 (7.0e-17)
  • rs10276303 (1.0e-15)
  • rs10866846 (2.0e-15)
  • rs7524102 (3.0e-15)
  • rs7838717 (5.0e-14)
  • rs6016142 (1.0e-13)
  • rs2306022 (9.0e-11)
  • rs9951109 (1.0e-10)
  • rs17433710 (2.0e-10)
  • rs9525927 (2.0e-10)
  • rs1509406 (3.0e-10)
  • rs977987 (5.0e-10)
  • rs7071275 (1.0e-06)
  • rs4792901 (3.0e-06)
  • rs7866181 (5.0e-06)
  • (show allshow less)
0.1650.703099Gr00198
GR00197Dupuytren's disease | HGVRS209021732829
  • rs16879765 (6.0e-39)
  • rs6519955 (3.0e-33)
  • rs611744 (8.0e-15)
  • rs11672517 (7.0e-14)
  • rs2912522 (2.0e-13)
  • rs8124695 (8.0e-10)
  • rs7524102 (3.0e-09)
  • rs10809650 (6.0e-09)
  • rs4730775 (3.0e-08)
  • rs2179367 (3.0e-07)
  • rs4789939 (6.0e-07)
  • rs4932194 (8.0e-07)
  • (show allshow less)
0.0700.632487Gr00197
GR00196Drug abuse | HGVRS455226202629
  • rs9829896 (4.0e-10)
0.0010.516102Gr00196
GR00195Drinking behavior | HGVRS304923364009
  • rs11066280 (3.0e-215)
0.0010.515939Gr00195
GR00194Disease-free survival in breast cancer | HGVRS653325867717
  • rs166870 (3.0e-07)
  • rs10825036 (4.0e-07)
0.0850.645463Gr00194
GR00193Disc degeneration (lumbar) | HGVRS374924216480
  • rs1245582 (4.0e-08)
0.0010.516329Gr00193
GR00192Digestive system disease | HGVRS368424121790
  • rs10419226 (4.0e-10)
  • rs11789015 (1.0e-09)
  • rs2687201 (5.0e-09)
  • rs4800353 (3.0e-07)
  • rs3784262 (7.0e-07)
  • rs7632500 (1.0e-06)
  • rs2178146 (1.0e-06)
  • rs2927438 (2.0e-06)
  • rs2342002 (7.0e-06)
  • rs11771429 (8.0e-06)
  • (show allshow less)
0.0030.52732Gr00192
GR00191Diffuse large B cell lymphoma | HGVRS509225261932
  • rs116446171 (2.0e-21)
  • rs13255292 (1.0e-12)
  • rs4733601 (4.0e-11)
  • rs2523607 (2.0e-10)
  • rs79480871 (4.0e-08)
  • rs79464052 (6.0e-08)
  • rs2681416 (8.0e-08)
  • rs45483501 (8.0e-06)
  • (show allshow less)
0.0230.576188Gr00191
GR00190Diarrhoeal Disease | HGVRS549127559109
  • rs12462111 (2.0e-07)
0.0010.516048Gr00190
GR00189Diarrhoeal Disease | HGVRS549027559109
  • rs8111874 (8.0e-14)
0.0020.520463Gr00189
GR00188Diarrhoeal Disease | HGVRS548927559109
  • rs35106244 (7.0e-11)
0.0070.54034Gr00188
GR00187Diarrhoeal Disease | HGVRS548827559109
  • rs116248771 (3.0e-06)
0.0000.500429Gr00187
GR00186Diabetic nephropathy | HGVRS609225476525
  • rs1326934 (6.0e-07)
0.0040.529879Gr00186
GR00185Diabetic nephropathy | HGVRS136021150874
  • rs6930576 (7.0e-07)
  • rs7769051 (2.0e-06)
  • rs2358944 (4.0e-06)
  • rs2106294 (4.0e-06)
  • rs773506 (6.0e-06)
0.0170.565468Gr00185
GR00184Dementia with Lewy bodies | HGVRS476029263008
  • rs429358 (3.0e-64)
  • rs7681440 (9.0e-13)
  • rs35749011 (7.0e-10)
  • rs897984 (1.0e-08)
0.0720.633807Gr00184
GR00183Curve progression in adolescent idiopathic scoliosis | HGVRS640629016859
  • rs1828853 (2.0e-09)
0.0010.515922Gr00183
GR00182Crohn's disease | HGVRS419725557950
  • rs11924265 (2.0e-08)
  • rs1520339 (6.0e-07)
  • rs2249296 (1.0e-06)
  • rs12122337 (1.0e-06)
  • rs9868898 (2.0e-06)
  • rs10929956 (2.0e-06)
  • (show allshow less)
0.0670.629331Gr00182
GR00181Crohn's disease | HGVRS361823850713
  • rs6856616 (4.0e-14)
  • rs10947261 (3.0e-12)
  • rs9271366 (5.0e-12)
  • rs2149085 (8.0e-12)
  • rs76418789 (2.0e-10)
  • rs11195128 (2.0e-10)
  • rs11235667 (7.0e-09)
  • rs751728 (1.0e-08)
  • (show allshow less)
0.0180.567998Gr00181
GR00180Crohn's disease | HGVRS270323128233
  • rs2066847 (6.0e-209)
  • rs12994997 (4.0e-70)
  • rs9264942 (5.0e-28)
  • rs9286879 (6.0e-22)
  • rs2024092 (8.0e-22)
  • rs3764147 (2.0e-21)
  • rs2945412 (9.0e-17)
  • rs6716753 (1.0e-16)
  • rs6651252 (1.0e-16)
  • rs2284553 (2.0e-16)
  • rs1728918 (5.0e-16)
  • rs516246 (1.0e-15)
  • rs6679677 (2.0e-15)
  • rs13204742 (8.0e-15)
  • rs212388 (3.0e-14)
  • rs13126505 (2.0e-12)
  • rs10065637 (4.0e-12)
  • rs12663356 (4.0e-12)
  • rs3897478 (2.0e-11)
  • rs4802307 (2.0e-10)
  • rs9491697 (4.0e-10)
  • rs7702331 (6.0e-10)
  • rs10865331 (1.0e-09)
  • rs17391694 (3.0e-09)
  • rs16967103 (4.0e-09)
  • rs864745 (4.0e-09)
  • rs17695092 (5.0e-09)
  • rs7015630 (1.0e-08)
  • rs6837335 (2.0e-08)
  • rs10486483 (3.0e-08)
  • (show allshow less)
0.0510.612408Gr00180
Displaying study simulation 376 - 400 of 579 in total